InhaleRX snags $38.5M in funding from VC biotech funder Clendon
InhaleRX is set to go ahead with clinical trials after Victorian VC firm Clendon handed IRX nearly $40M in cash.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ASL | Media | 19/10/24 | 17 | 3.8K | |||
|
|||||||
ASL | Ann: Application for quotation of securities - ASL | 18/10/24 | 0 | 196 | |||
|
|||||||
ASL | Ann: Trading Halt | 17/10/24 | 43 | 17K | |||
|
|||||||
ASL | Ann: AGM Date and Closing Date for Director Nominations | 09/10/24 | 0 | 203 | |||
|
|||||||
ASL | Ann: Application for quotation of securities - ASL | 09/10/24 | 0 | 161 | |||
|
|||||||
ASL | Ann: Early completion of final deferred acquisition payment | 02/10/24 | 0 | 378 | |||
|
|||||||
ASL | Ann: Chairman Transition - David Southam appointed | 01/10/24 | 0 | 311 | |||
|
|||||||
ASL | Ann: Change in substantial holding | 27/09/24 | 1 | 607 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |